Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer

Trastuzumab is an effective treatment for patients with metastatic breast cancer (MBC) that overexpresses HER-2. A high incidence of brain metastases (BM) has been noted in patients receiving trastuzumab. A retrospective chart review was conducted of 100 patients commencing trastuzumab for metastati...

Descripción completa

Detalles Bibliográficos
Autores principales: Clayton, A J, Danson, S, Jolly, S, Ryder, W D J, Burt, P A, Stewart, A L, Wilkinson, P M, Welch, R S, Magee, B, Wilson, G, Howell, A, Wardley, A M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364775/
https://www.ncbi.nlm.nih.gov/pubmed/15266327
http://dx.doi.org/10.1038/sj.bjc.6601970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364775/
https://www.ncbi.nlm.nih.gov/pubmed/15266327
http://dx.doi.org/10.1038/sj.bjc.6601970

Ejemplares similares